Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue: +1.57%
EPS: −75.4%
Free cash flow: +278.7%
Total debt: −14.7%

Quarter to September 2026, against a year earlier

61.09 3.03 +5.22%

Follow BRKR

Alert me

Market cap: $8.9B
P/E: 0.0×
Fwd P/E: −412×
Dividend yield: 0.34%
F-score: 4/9
Altman Z: 2.43
Beneish M: −2.56
Dividend safety: 34/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bruker Corporation (BRKR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Bruker Corporation (BRKR) trades at a price to free cash flow of 32.9×. Over the past ten years it has ranged from 16.3× (February 2016) to 527× (November 2025); the current reading is higher than 36% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BRKR/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Bruker Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BRKR/metrics/price-to-free-cash-flow">Bruker Corporation (BRKR) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	105×	93.33%
FY2024	54.3×	37.53%
FY2023	39.5×	(29.24%)
FY2022	55.8×	(3.30%)
FY2021	57.7×	80.73%
FY2020	31.9×	(28.86%)
FY2019	44.9×	108.25%
FY2018	21.6×	(41.93%)
FY2017	37.1×	27.49%
FY2016	29.1×	57.45%

Period	Price to free cash flow	Change
Sep 2026	36.6×	(52.55%)
Jun 2026	77.2×	6.89%
Mar 2026	72.2×	(31.21%)
Dec 2025	105×	(69.77%)
43 more quarters	Free account

Against its own ten years

Low 16.3× High 527×

Ten-year median 37.4×

Current reading's percentile 36

Company	Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare	7.1×
GMED Globus Medical, Inc. compare	14.5×
BIO Bio-Rad Laboratories, Inc. compare	30.0×
BIO.B Bio-Rad Laboratories, Inc. compare	30.7×
BRKR Bruker Corporation	32.9×
PODD Insulet Corporation compare	46.4×
PEN Penumbra, Inc. compare	63.1×
TXG 10x Genomics compare	63.3×
GKOS Glaukos Corporation compare	360×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Bruker Corporation (BRKR) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BRKR

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on BRKR

Stockrow Weekly